DIAbetes-PREvention Trial.
Suspended
- Conditions
- Coronary artery disease (CAD): PCI or CABG in stable CAD, or post STEMI and post non-STEMI, Cardiac rehabilitation , Diabetes Mellitus
- Registration Number
- NL-OMON21355
- Lead Sponsor
- Isala Klinieken, te ZwolleMaatschap Cardiologie, Interne en sportgeneeskunde, Isala Klinieken.
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- Not specified
- Target Recruitment
- 78
Inclusion Criteria
1. Pcoronary artery disease (CAD): PCI or CABG in stable CAD, or post STEMI and post non-STEMI (inclusion within 2 month after admission);
2. Age ≥ 18 years;
Exclusion Criteria
1. Known diabetics, with or without anti-diabetic medication;
2. Contra-indications for Metformine use as stated in the medication registration;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A 10% reduction in HbA1c at one year in patients with coronary artery disease (PCI or CABG in stable CAD, or post STEMI and post non-STEMI patients) that have pre-diabetes.
- Secondary Outcome Measures
Name Time Method 1. hsCRP;<br /><br>2. LDL cholesterol;<br /><br>3. MACE at one year FUP;<br /><br>4. Exercise capacity.